AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

EVOLVING AZIMUTH IN MUSA CONTEXT

RecruitingNAAges 18 Years - anyAllFondazione IRCCS Ca' Granda, Ospedale Maggiore Poโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Have been diagnosed with chronic CS according to the ESC guidelines; * Over 18 years of age; * Patients admitted to hospital or with access to first aid within the last year; * Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application); * Wi-Fi or 3G coverage at home; * Ability to give written informed consent. Exclusion Criteria: * Severe psychiatric disorder * Inability to use portable technologies * Patients unable to use the equipment provided * Patients who deny consent to study participation
๐Ÿ’Š

What it tests

  • Telemonitoring app
๐Ÿ“

Where

1 site
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy